Cite
HARVARD Citation
Mutlu, L. et al. (n.d.). EP015/#546 In vitro and in vivo efficacy of trastuzumab deruxtecan (T-DXd) in epithelial ovarian cancer with HER2/NEU overexpression. International journal of gynecological cancer. p. A54. [Online].